abstract |
The invention discloses a class of compounds that can be used as SHP2 inhibitors and their use in preparing medicines for SHP2-mediated diseases, especially Noonan syndrome, leopard skin syndrome and juvenile myelomonocytic leukemia , acute myeloid leukemia, neuroblastoma, melanoma, and breast, lung, and colon cancer. |